Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Neurology and Therapy|July 1, 2026
AQP4-IgG Dynamics and Exploratory Assessment of SERA-3 in Neuromyelitis Optica Spectrum Disorder Treated with SatralizumabMiaoxin Yu, Xiang Li, Lei Cui, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's diseaseJiangli Jin, Jiong Chen, Clémence Cavaillès, et al.Frontiers in Aging Neuroscience|January 8, 2024
Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer's diseaseYuye Wang, Yu Sun, Yu Wang, et al.Journal of Alzheimer'S Disease : JAD|November 21, 2019
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's DiseaseJianping Jia, Yong Ji, Tao Feng, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2019
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formationShujuan Zhang, Jianxiang Zhang, Dongfeng Wei, et al.Frontiers in Aging Neuroscience|January 3, 2025
Association between Alzheimer's disease pathologic products and age and a pathologic product-based diagnostic model for Alzheimer's diseaseWeizhe Zhen, Yu Wang, Hongjun Zhen, et al.Alzheimer'S Research & Therapy|November 5, 2023
Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learningYuye Wang, Yu Sun, Yu Wang, et al.Neural Regeneration Research|September 11, 2014
APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's diseaseQin Zhou, Dantao Peng, Xinrui Yuan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2017
Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's diseaseJianping Jia, Serge Gauthier, Sarah Pallotta, et al.Age and Ageing|January 25, 2025
A mobile interactive cognitive self-assessment scale for screening cognitive impairment due to Alzheimer's diseaseKexin Xie, Juan Huang, Ting Chen, et al.Pageof 8